Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Total Current Liabilities (2016 - 2026)

Dexcom has reported Total Current Liabilities over the past 17 years, most recently at $2.2 billion for Q1 2026.

  • Quarterly Total Current Liabilities fell 26.78% to $2.2 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.2 billion through Mar 2026, down 26.78% year-over-year, with the annual reading at $2.1 billion for FY2025, 26.93% down from the prior year.
  • Total Current Liabilities was $2.2 billion for Q1 2026 at Dexcom, up from $2.1 billion in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $3.3 billion in Q3 2025 and troughed at $711.4 million in Q1 2022.
  • The 5-year median for Total Current Liabilities is $1.8 billion (2022), against an average of $2.0 billion.
  • Year-over-year, Total Current Liabilities soared 162.16% in 2023 and then fell 26.93% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $1.8 billion in 2022, then decreased by 15.4% to $1.6 billion in 2023, then skyrocketed by 88.43% to $2.9 billion in 2024, then fell by 26.93% to $2.1 billion in 2025, then increased by 3.79% to $2.2 billion in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Total Current Liabilities are $2.2 billion (Q1 2026), $2.1 billion (Q4 2025), and $3.3 billion (Q3 2025).